These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 3266178)

  • 1. [The activation of natural killer cells. A new approach to adoptive immunotherapy of tumors].
    Schwarz R
    Fortschr Med; 1988 Oct; 106(29):579-80. PubMed ID: 3266178
    [No Abstract]   [Full Text] [Related]  

  • 2. Lymphokine-activated killer cells: a new approach to immunotherapy of cancer.
    Rosenberg S
    J Natl Cancer Inst; 1985 Oct; 75(4):595-603. PubMed ID: 3876465
    [No Abstract]   [Full Text] [Related]  

  • 3. [Adoptive immunotherapy using cytapheresis].
    Takago H; Sasakawa H; Kanizawa Y; Nojiri H; Ueno Y
    Rinsho Ketsueki; 1986 Jul; 27(7):1242-6. PubMed ID: 3491233
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunotherapy of cancer: the end of the beginning?
    Durant JR
    N Engl J Med; 1987 Apr; 316(15):939-41. PubMed ID: 3493434
    [No Abstract]   [Full Text] [Related]  

  • 5. [Using LAK cells in the adoptive immunotherapy in cancers].
    Urushizaki I
    Rinsho Ketsueki; 1987 Oct; 28(10):1897-8. PubMed ID: 3502569
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunotherapy of cancer by systemic administration of lymphoid cells plus interleukin-2.
    Rosenberg SA
    J Biol Response Mod; 1984 Oct; 3(5):501-11. PubMed ID: 6389777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adoptive immunotherapy of cancer using lymphokine activated killer cells and recombinant interleukin-2.
    Rosenberg SA
    Important Adv Oncol; 1986; ():55-91. PubMed ID: 3330541
    [No Abstract]   [Full Text] [Related]  

  • 8. [Use of interleukin 2-activated lymphocytes (LAK cells) in adoptive immunotherapy of neoplasms].
    Robak T
    Pol Tyg Lek; 1988 Nov; 43(47):1491-5. PubMed ID: 3266975
    [No Abstract]   [Full Text] [Related]  

  • 9. [Adoptive immunotherapy: a new therapeutic approach to cancer based on interleukin 2].
    Sculier JP; Bron D; Delforge A; Stryckmans P; Klastersky J
    Rev Med Brux; 1987 Mar; 8(3):133-9. PubMed ID: 3495843
    [No Abstract]   [Full Text] [Related]  

  • 10. [Interleukin 2].
    Taguchi T; Kimoto Y
    Gan To Kagaku Ryoho; 1987 May; 14(5 Pt 1):1203-7. PubMed ID: 3495239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [LAK cells and cancer].
    Taguchi T; Kimoto Y
    Gan To Kagaku Ryoho; 1986 Dec; 13(12):3327-33. PubMed ID: 3539024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [LAK-adoptive immunotherapy with cytapheresis].
    Urushizaki I
    Rinsho Ketsueki; 1988 Nov; 29(11):1965-72. PubMed ID: 3266257
    [No Abstract]   [Full Text] [Related]  

  • 13. [Adoptive immunotherapy of malignant diseases using normal allogeneic LAK cells].
    Kimoto Y; Tanji Y; Tanaka T; Taguchi T
    Gan To Kagaku Ryoho; 1987 Jun; 14(6 Pt 1):1884-9. PubMed ID: 3496050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Adoptive immunotherapy using interleukin-2 and interleukin-2-activated lymphocytes].
    van de Loosdrecht AA; Ossenkoppele GJ; Beelen RH
    Ned Tijdschr Geneeskd; 1989 Oct; 133(40):1994-5. PubMed ID: 2812087
    [No Abstract]   [Full Text] [Related]  

  • 15. Adoptive immunotherapy of malignant diseases with IL-2-activated lymphocytes.
    Kimoto Y; Taguchi T
    Biken J; 1987 Jun; 30(2):29-38. PubMed ID: 3501954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Adoptive immunotherapy of malignant diseases with LAK cells].
    Kimoto Y; Tanji Y; Tanaka T; Taguchi T
    Gan To Kagaku Ryoho; 1987 Mar; 14(3 Pt 1):687-92. PubMed ID: 3493732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunotherapy of cancer with lymphokine-activated killer cells and recombinant interleukin-2.
    Rosenberg SA; Mulé JJ
    Surgery; 1985 Sep; 98(3):437-44. PubMed ID: 3898451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Summary: potential of interleukin-2 for the therapy of cancer.
    Herberman RB
    J Biol Response Mod; 1984 Oct; 3(5):527-32. PubMed ID: 6389778
    [No Abstract]   [Full Text] [Related]  

  • 19. [Adoptive immunotherapy of cancer patients with lymphokine-activated killer cells].
    Taguchi T; Domoto K
    Gan To Kagaku Ryoho; 1987 Mar; 14(3 Pt 2):914-21. PubMed ID: 3494428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adoptive immunotherapy of murine hepatic metastases with lymphokine activated killer (LAK) cells and recombinant interleukin 2 (RIL 2) can mediate the regression of both immunogenic and nonimmunogenic sarcomas and an adenocarcinoma.
    Lafreniere R; Rosenberg SA
    J Immunol; 1985 Dec; 135(6):4273-80. PubMed ID: 3877766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.